Zobrazeno 1 - 8
of 8
pro vyhledávání: '"Sandra Bode"'
Autor:
Marco J Haenssgen, Sengchanh Kounnavong, Shogo Kubota, Sayaka Horiuchi, Ying-Ru Jacqueline Lo, Elizabeth M Elliott, Ketkesone Phrasisombath, Phonepaseuth Ounaphom, Laty Phimmachak, Ounkham Souksavanh, William Robert Everett Seal, Vilaythone Sounthone Xaymongkhonh, Khanphoungeune Volaot, Sandra Bode, Asiya Odugleh-Kolev
Publikováno v:
BMJ Global Health, Vol 9, Iss 9 (2024)
Community engagement and local governance are important components of health interventions aiming to empower local populations. Yet, there is limited evidence on how to effectively engage with communities and codevelop interventions, especially in So
Externí odkaz:
https://doaj.org/article/c803535cd40340ecaff41c21fe99346f
Autor:
Pauline Caillard, Youssef Bennis, Cédric Boudot, Denis Chatelain, Pierre Rybarczyk, Agnès Boullier, Sabrina Poirot, Dimitri Titeca-Beauport, Sandra Bodeau, Gabriel Choukroun, Saïd Kamel, Isabelle Six, Julien Maizel
Publikováno v:
Renal Failure, Vol 46, Iss 2 (2024)
Acute kidney injury (AKI) and chronic kidney disease (CKD) are major health concerns due to their increasing incidence and high mortality. They are interconnected syndromes; AKI without recovery evolves into acute kidney disease (AKD), which can indi
Externí odkaz:
https://doaj.org/article/96ba26bb60574742a2ef773f4dfa8e7a
Autor:
Jérôme Jeanblanc, Pierre Sauton, Charles Houdant, Sandra Fernandez Rodriguez, Sofia Vilelas de Sousa, Virginie Jeanblanc, Sandra Bodeau, Laurence Labat, Marion Soichot, Florence Vorspan, Mickael Naassila
Publikováno v:
Frontiers in Pharmacology, Vol 14 (2023)
Introduction: Clinical studies on the effectiveness of Baclofen in alcohol use disorder (AUD) yielded mixed results possibly because of differential effects of the enantiomers and sex-related differences. Here we examined the effect of the different
Externí odkaz:
https://doaj.org/article/1ee480dfcf4e42909cb61bc7b687cc6c
Autor:
Pauline Caillard, Youssef Bennis, Isabelle Six, Sandra Bodeau, Saïd Kamel, Gabriel Choukroun, Julien Maizel, Dimitri Titeca-Beauport
Publikováno v:
Toxins, Vol 14, Iss 5, p 336 (2022)
Acute kidney injury (AKI) is a frequent disease encountered in the hospital, with a higher incidence in intensive care units. Despite progress in renal replacement therapy, AKI is still associated with early and late complications, especially cardiov
Externí odkaz:
https://doaj.org/article/304fe81d4e6048ce82ee476dc2f60b44
Autor:
Camille André, Touria Mernissi, Gabriel Choukroun, Youssef Bennis, Saïd Kamel, Sophie Liabeuf, Sandra Bodeau
Publikováno v:
Toxins, Vol 14, Iss 1, p 15 (2021)
The renal elimination of uremic toxins (UTs) can be potentially altered by drugs that inhibit organic anion transporters 1/3 (OAT1/OAT3). The objective of the present study was to determine whether the prescription of at least one OAT1/OAT3 inhibitor
Externí odkaz:
https://doaj.org/article/07bbfd9e515746fbb5389b6cf1ea5c35
Autor:
Benjamin Batteux, Sandra Bodeau, Camille André, Anne-Sophie Hurtel-Lemaire, Valérie Gras-Champel, Isabelle Desailly-Henry, Kamel Masmoudi, Youssef Bennis, Ziad A. Massy, Saïd Kamel, Gabriel Choukroun, Sophie Liabeuf
Publikováno v:
Toxins, Vol 12, Iss 11, p 715 (2020)
Although uremic osteoporosis is a component of mineral and bone disorder in chronic kidney disease, uremic toxin (UT) concentrations in patients with end-stage kidney disease and bone mineral density (BMD) changes after kidney transplantation have no
Externí odkaz:
https://doaj.org/article/62959a0dab984bd09b01d28ba904560e
Autor:
Youssef Bennis, Yan Cluet, Dimitri Titeca-Beauport, Najeh El Esper, Pablo Ureña, Sandra Bodeau, Christian Combe, Bertrand Dussol, Denis Fouque, Gabriel Choukroun, Sophie Liabeuf
Publikováno v:
Toxins, Vol 11, Iss 5, p 279 (2019)
High serum levels of gut-derived uremic toxins, especially p-cresyl sulfate (pCS), indoxyl sulfate (IS) and indole acetic acid (IAA), have been linked to adverse outcomes in patients with chronic kidney disease (CKD). Sevelamer carbonate could repres
Externí odkaz:
https://doaj.org/article/4790423124b8492190b57318e3cbd841
Autor:
Aurélie Lenglet, Sophie Liabeuf, Sandra Bodeau, Loïc Louvet, Aurélien Mary, Agnès Boullier, Anne Sophie Lemaire-Hurtel, Alexia Jonet, Pascal Sonnet, Said Kamel, Ziad A. Massy
Publikováno v:
Toxins, Vol 8, Iss 11, p 339 (2016)
N-methyl-2-pyridone-5-carboxamide (2PY, a major metabolite of nicotinamide, NAM) was recently identified as a uremic toxin. Recent interventional trials using NAM to treat high levels of phosphorus in end-stage renal disease have highlighted new pote
Externí odkaz:
https://doaj.org/article/66d268a591eb4972bfeb703207495259